Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin

1.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. https://doi.org/10.3322/caac.21551.CrossRefPubMed

2.

Ramaswami R, Harding V, Newsom-Davis T. Novel cancer therapies: treatments driven by tumour biology. Postgrad Med J. 2013;89(1057):652. https://doi.org/10.1136/postgradmedj-2012-131533.CrossRefPubMed

3.

Nurgali K, Jagoe RT, Abalo R. Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae? Front Pharmacol. 2018;9:245. https://doi.org/10.3389/fphar.2018.00245.CrossRefPubMedPubMedCentral

4.

Chahar MK, Sharma N, Dobhal MP, Joshi YC. Flavonoids: a versatile source of anticancer drugs. Pharmacogn Rev. 2011;5(9):1–12. https://doi.org/10.4103/0973-7847.79093.CrossRefPubMedPubMedCentral

5.

Yadegarynia S, Pham A, Ng A, Nguyen D, Lialiutska T, Bortolazzo A, et al. Profiling flavonoid cytotoxicity in human breast cancer cell lines: determination of structure-function relationships. Nat Prod Commun. 2012;7(10):1295–304.PubMed

6.

Talebi M, İlgün S, Ebrahimi V, Talebi M, Farkhondeh T, Ebrahimi H, et al. Zingiber officinale ameliorates Alzheimer’s disease and cognitive impairments: lessons from preclinical studies. Biomed Pharmacother. 2021;133:111088. https://doi.org/10.1016/j.biopha.2020.111088.CrossRefPubMed

7.

Siddiqui A, Badruddeen, Akhtar J, Uddin M.S S, Khan MI, Khalid M, et al. A naturally occurring flavone (chrysin): chemistry, occurrence, pharmacokinetic, toxicity, molecular targets and medicinal properties. J Biol Act Prod Nat. 2018;8(4):208–27. https://doi.org/10.1080/22311866.2021.1887762.

8.

Mani R, Natesan V. Chrysin: sources, beneficial pharmacological activities, and molecular mechanism of action. Phytochemistry. 2018;145:187–96. https://doi.org/10.1016/j.phytochem.2017.09.016.CrossRefPubMed

9.

Hadjmohammadi MR, Nazari SS. Separation optimization of quercetin, hesperetin and chrysin in honey by micellar liquid chromatography and experimental design. J Sep Sci. 2010;33(20):3144–51. https://doi.org/10.1002/jssc.201000326.CrossRefPubMed

10.

Talebi M, Talebi M, Farkhondeh T, Samarghandian S. Molecular mechanism-based therapeutic properties of honey. Biomed Pharmacother. 2020;130:110590. https://doi.org/10.1016/j.biopha.2020.110590.CrossRefPubMed

11.

Zhao X, Shu G, Chen L, Mi X, Mei Z, Deng X. A flavonoid component from Docynia delavayi (Franch.) Schneid represses transplanted H22 hepatoma growth and exhibits low toxic effect on tumor-bearing mice. Food Chem Toxicol. 2012;50(9):3166–73. https://doi.org/10.1016/j.fct.2012.05.039.CrossRefPubMed

12.

Kamat S, Kumari M, Sajna KV, Jayabaskaran C. Endophytic fungus, Chaetomium globosum, associated with marine green alga, a new source of Chrysin. Sci Rep. 2020;10(1):18726. https://doi.org/10.1038/s41598-020-72497-3.CrossRefPubMedPubMedCentral

13.

Boothapandi M, Ravichandran R. Antiproliferative activity of chrysin (5, 7-dihydroxyflavone) from Indigofera tinctoria on human epidermoid carcinoma (A431) cells. Eur J Integr Med. 2018;24:71–8. https://doi.org/10.1016/j.eujim.2018.10.015.CrossRef

14.

Chan EWC, Wong SK, Tangah J, Inoue T, Chan HT. A synopsis on flavonoids from the roots of Scutellaria baicalensis with some insights on baicalein and its anti-cancer properties. J Chin Pharm Sci. 2019;28(4):217–28. https://doi.org/10.5246/jcps.2019.04.022.CrossRef

15.

da Cunha MG, Franchin M, Galvão L, de Ruiz A, de Carvalho JE, Ikegaki M, et al. Antimicrobial and antiproliferative activities of stingless bee Melipona scutellaris geopropolis. BMC Complement Altern Med. 2013;13. https://doi.org/10.1186/1472-6882-13-23.

16.

Dinda B, Silsarma I, Dinda M, Rudrapaul P. Oroxylum indicum (L.) Kurz, an important Asian traditional medicine: from traditional uses to scientific data for its commercial exploitation. J Ethnopharmacol. 2015;161:255–78. https://doi.org/10.1016/j.jep.2014.12.027.CrossRefPubMed

17.

Huang C, Wei YX, Shen MC, Tu YH, Wang CC, Huang HC. Chrysin, abundant in Morinda citrifolia fruit water-EtOAc extracts, combined with apigenin synergistically induced apoptosis and inhibited migration in human breast and liver cancer cells. J Agric Food Chem. 2016;64(21):4235–45. https://doi.org/10.1021/acs.jafc.6b00766.CrossRefPubMed

18.

Déciga-Campos M, Mata R, Rivero-Cruz I. Antinociceptive pharmacological profile of Dysphania graveolens in mouse. Biomed Pharmacother. 2017;89:933–8. https://doi.org/10.1016/j.biopha.2017.02.096.CrossRefPubMed

19.

Catchpole O, Mitchell K, Bloor S, Davis P, Suddes A. Antiproliferative activity of New Zealand propolis and phenolic compounds vs human colorectal adenocarcinoma cells. Fitoterapia. 2015;106:167–74. https://doi.org/10.1016/j.fitote.2015.09.004.CrossRefPubMed

20.

Harminder, Singh V, Chaudhary AK. A review on the taxonomy, ethnobotany, chemistry and pharmacology of Oroxylum indicum vent. Indian J Pharm Sci. 2011;73(5):483–90. https://doi.org/10.4103/0250-474X.98981.

21.

Zhang Q, Zheng Y, Hu X, Hu X, Lv W, Lv D, et al. Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Alpinia oxyphylla Miquel: a review. J Ethnopharmacol. 2018;224:149–68. https://doi.org/10.1016/j.jep.2018.05.002.CrossRefPubMed

22.

Laishram S, Moirangthem DS, Borah JC, Pal BC, Suman P, Gupta SK, et al. Chrysin rich Scutellaria discolor Colebr. induces cervical cancer cell death via the induction of cell cycle arrest and caspase-dependent apoptosis. Life Sci. 2015;143:105–13. https://doi.org/10.1016/j.lfs.2015.10.035.CrossRefPubMed

23.

Chassagne F, Haddad M, Amiel A, Phakeovilay C, Manithip C, Bourdy G, et al. A metabolomic approach to identify anti-hepatocarcinogenic compounds from plants used traditionally in the treatment of liver diseases. Fitoterapia. 2018;127:226–36. https://doi.org/10.1016/j.fitote.2018.02.021.CrossRefPubMed

24.

Zhang L, Zhang J, Qi B, Jiang G, Liu J, Zhang P, et al. The anti-tumor effect and bioactive phytochemicals of Hedyotis diffusa willd on ovarian cancer cells. J Ethnopharmacol. 2016;192:132–9. https://doi.org/10.1016/j.jep.2016.07.027.CrossRefPubMed

25.

Narayan C, Kumar A. Antineoplastic and immunomodulatory effect of polyphenolic components of Achyranthes aspera (PCA) extract on urethane induced lung cancer in vivo. Mol Biol Rep. 2014;41(1):179–91. https://doi.org/10.1007/s11033-013-2850-6.CrossRefPubMed

26.

Chokchaisiri R, Kunkaewom S, Chokchaisiri S, Ganranoo L, Chalermglin R, Suksamrarn A. Potent cytotoxicity against human small cell lung cancer cells of the heptenes from the stem bark of Xylopia pierrei Hance. Med Chem Res. 2017;26(6):1291–6. https://doi.org/10.1007/s00044-017-1843-8.CrossRef

27.

Wadibhasme PG, Ghaisas MM, Thakurdesai PA. Anti-asthmatic potential of chrysin on ovalbumin-induced bronchoalveolar hyperresponsiveness in rats. Pharm Biol. 2011;49(5):508–15. https://doi.org/10.3109/13880209.2010.521754.CrossRefPubMed

28.

Li X, Wang JN, Huang JM, Xiong XK, Chen MF, Ong CN, et al. Chrysin promotes tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced apoptosis in human cancer cell lines. Toxicol In Vitro. 2011;25(3):630–5. https://doi.org/10.1016/j.tiv.2010.12.013.CrossRefPubMed

29.

Tsuji PA, Walle T. Benzo[a]pyrene-induced cytochrome P450 1A and DNA binding in cultured trout hepatocytes—inhibition by plant polyphenols. Chem Biol Interact. 2007;169(1):25–31. https://doi.org/10.1016/j.cbi.2007.05.001.CrossRefPubMedPubMedCentral

30.

Lirdprapamongkol K, Sakurai H, Abdelhamed S, Yokoyama S, Maruyama T, Athikomkulchai S, et al. A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells. Oncol Rep. 2013;30(5):2357–64. https://doi.org/10.3892/or.2013.2667.CrossRefPubMed

31.

Russo P, Del Bufalo A, Cesario A. Flavonoids acting on DNA topoisomerases: recent advances and future perspectives in cancer therapy. Curr Med Chem. 2012;19(31):5287–93. https://doi.org/10.2174/092986712803833272.CrossRefPubMed

32.

Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001;50(6):537–46.PubMed

33.

Bai J, Luo Y, Zhanchun S, Fan W, Wang Z, Luan T, et al. Effects and the mechanisms of chrysin on sepsis-associated acute lung injury of rats Chrysin inhibits acute lung injury. Life Sci J. 2013;10:1052–8.

34.

Tian SS, Jiang FS, Zhang K, Zhu XX, Jin B, Lu JJ, et al. Flavonoids from the leaves of Carya cathayensis Sarg. inhibit vascular endothelial growth factor-induced angiogenesis. Fitoterapia. 2014;92:34–40. https://doi.org/10.1016/j.fitote.2013.09.016.CrossRefPubMed

35.

Kang MK, Park SH, Choi YJ, Shin D, Kang YH. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition. J Mol Med. 2015;93(7):759–72. https://doi.org/10.1007/s00109-015-1301-3.CrossRefPubMed

36.

Anandhi R, Thomas PA, Geraldine P. Evaluation of the anti-atherogenic potential of chrysin in Wistar rats. Mol Cell Biochem. 2014;385(1–2):103–13. https://doi.org/10.1007/s11010-013-1819-z.CrossRefPubMed

37.

Samarghandian S, Azimi-Nezhad M, Samini F, Farkhondeh T. Chrysin treatment improves diabetes and its complications in liver, brain, and pancreas in streptozotocin-induced diabetic rats. Can J Physiol Pharmacol. 2016;94(4):388–93. https://doi.org/10.1139/cjpp-2014-0412.CrossRefPubMed

38.

Li Y, Li YP, He J, Liu D, Zhang QZ, Li K, et al. The relationship between pharmacological properties and structure–activity of chrysin derivatives. Mini Rev Med Chem. 2019;19(7):555–68. https://doi.org/10.2174/1389557518666180424094821.CrossRefPubMed

39.

Harris GK, Qian Y, Leonard SS, Sbarra DC, Shi X. Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells. J Nutr. 2006;136(6):1517–21. https://doi.org/10.1093/jn/136.6.1517.CrossRefPubMed

40.

Tsuji PA, Walle T. Cytotoxic effects of the dietary flavones chrysin and apigenin in a normal trout liver cell line. Chem Biol Interact. 2008;171(1):37–44. https://doi.org/10.1016/j.cbi.2007.08.007.CrossRefPubMed

41.

Rana AC, Gulliya B. Chemistry and pharmacology of flavonoids—a review. Indian J Pharm Educ Res. 2019;53(1):8–20. https://doi.org/10.5530/ijper.53.1.3.CrossRef

42.

Nabavi SF, Braidy N, Habtemariam S, Orhan IE, Daglia M, Manayi A, et al. Neuroprotective effects of chrysin: from chemistry to medicine. Neurochem Int. 2015;90:224–31. https://doi.org/10.1016/j.neuint.2015.09.006.CrossRefPubMed

43.

Wang QQ, Cheng N, Yi WB, Peng SM, Zou XQ. Synthesis, nitric oxide release, and α-glucosidase inhibition of nitric oxide donating apigenin and chrysin derivatives. Bioorg Med Chem. 2014;22(5):1515–21. https://doi.org/10.1016/j.bmc.2014.01.038.CrossRefPubMed

44.

Dao TT, Chi YS, Kim J, Kim HP, Kim S, Park H. Synthesis and inhibitory activity against COX-2 catalyzed prostaglandin production of chrysin derivatives. Bioorg Med Chem Lett. 2004;14(5):1165–7. https://doi.org/10.1016/j.bmcl.2003.12.087.CrossRefPubMed

45.

Zou XQ, Peng SM, Hu CP, Tan LF, Yuan Q, Deng HW, et al. Synthesis, characterization and vasculoprotective effects of nitric oxide-donating derivatives of chrysin. Bioorg Med Chem. 2010;18(9):3020–5. https://doi.org/10.1016/j.bmc.2010.03.056.CrossRefPubMed

46.

Peng SM, Zou XQ, Ding HL, Ding YL, Lin YB. Synthesis and promotion angiogenesis effect of chrysin derivatives coupled to NO donors. Bioorg Med Chem Lett. 2009;19(4):1264–6. https://doi.org/10.1016/j.bmcl.2008.12.116.CrossRefPubMed

47.

Park H, Dao TT, Kim HP. Synthesis and inhibition of PGE2 production of 6,8-disubstituted chrysin derivatives. Eur J Med Chem. 2005;40(9):943–8. https://doi.org/10.1016/j.ejmech.2005.04.013.CrossRefPubMed

48.

Zhu ZY, Wang WX, Wang ZQ, Chen LJ, Zhang JY, Liu XC, et al. Synthesis and antitumor activity evaluation of chrysin derivatives. Eur J Med Chem. 2014;75:297–300. https://doi.org/10.1016/j.ejmech.2013.12.044.CrossRefPubMed

49.

Zhang T, Chen X, Qu L, Wu J, Cui R, Zhao Y. Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells. Bioorg Med Chem. 2004;12(23):6097–105. https://doi.org/10.1016/j.bmc.2004.09.013.CrossRefPubMed

50.

Goto H, Yanagimachi M, Goto S, Takeuchi M, Kato H, Yokosuka T, et al. Methylated chrysin reduced cell proliferation, but antagonized cytotoxicity of other anticancer drugs in acute lymphoblastic leukemia. Anticancer Drugs. 2012;23(4):417–25. https://doi.org/10.1097/CAD.0b013e32834fb731.CrossRefPubMed

51.

Shin JS, Kim KS, Kim MB, Jeong JH, Kim BK. Synthesis and hypoglycemic effect of chrysin derivatives. Bioorg Med Chem Lett. 1999;9(6):869–74. https://doi.org/10.1016/S0960-894X(99)00092-X.CrossRefPubMed

52.

Debnath S, Kanakaraju M, Islam M, Yeeravalli R, Sen D, Das A. In silico design, synthesis and activity of potential drug-like chrysin scaffold-derived selective EGFR inhibitors as anticancer agents. Comput Biol Chem. 2019;83. https://doi.org/10.1016/j.compbiolchem.2019.107156.

53.

Zhu Y, Yao X, Long J, Li R, Liu Y, Yang Z, et al. Fluorine-containing chrysin derivatives: synthesis and biological activity. Nat Prod Commun. 2019;14(9). https://doi.org/10.1177/1934578X19878921.

54.

Mistry BM, Patel RV, Keum YS, Kim DH. Chrysin-benzothiazole conjugates as antioxidant and anticancer agents. Bioorg Med Chem Lett. 2015;25(23):5561–5. https://doi.org/10.1016/j.bmcl.2015.10.052.CrossRefPubMed

55.

Walle T, Otake Y, Brubaker JA, Walle UK, Halushka PV. Disposition and metabolism of the flavonoid chrysin in normal volunteers. Br J Clin Pharmacol. 2001;51(2):143–6. https://doi.org/10.1111/j.1365-2125.2001.01317.x.CrossRefPubMedPubMedCentral

56.

Galijatovic A, Otake Y, Walle UK, Walle T. Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells. Xenobiotica. 1999;29(12):1241–56. https://doi.org/10.1080/004982599237912.CrossRefPubMed

57.

Ge S, Gao S, Yin T, Hu M. Determination of pharmacokinetics of chrysin and its conjugates in wild-type FVB and Bcrp1 knockout mice using a validated LC-MS/MS method. J Agric Food Chem. 2015;63(11):2902–10. https://doi.org/10.1021/jf5056979.CrossRefPubMed

58.

Kao YC, Zhou C, Sherman M, Laughton CA, Chen S. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study. Environ Health Perspect. 1998;106(2):85–92. https://doi.org/10.1289/ehp.9810685.CrossRefPubMedPubMedCentral

59.

Anari E, Akbarzadeh A, Zarghami N. Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line. Artif Cells Nanomed Biotechnol. 2016;44(6):1410–6. https://doi.org/10.3109/21691401.2015.1029633.CrossRefPubMed

60.

Liang Y, Deng X, Zhang L, Peng X, Gao W, Cao J, et al. Terminal modification of polymeric micelles with π-conjugated moieties for efficient anticancer drug delivery. Biomaterials. 2015;71:1–10. https://doi.org/10.1016/j.biomaterials.2015.08.032.CrossRefPubMed

61.

Davatgaran-Taghipour Y, Masoomzadeh S, Farzaei MH, Bahramsoltani R, Karimi-Soureh Z, Rahimi R, et al. Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective. Int J Nanomed. 2017;12:2689–702. https://doi.org/10.2147/IJN.S131973.CrossRef

62.

Deldar Y, Pilehvar-Soltanahmadi Y, Dadashpour M, Montazer Saheb S, Rahmati-Yamchi M, Zarghami N. An in vitro examination of the antioxidant, cytoprotective and anti-inflammatory properties of chrysin-loaded nanofibrous mats for potential wound healing applications. Artif Cells Nanomed Biotechnol. 2018;46(4):706–16. https://doi.org/10.1080/21691401.2017.1337022.CrossRefPubMed

63.

Lee JA, Jung BG, Kim TH, Kim YM, Park MH, Hyun PM, et al. Poly d, l-lactide-co-glycolide (PLGA) nanoparticle-encapsulated honeybee (Apis melifera) venom promotes clearance of Salmonella enterica serovar Typhimurium infection in experimentally challenged pigs through the up-regulation of T helper type 1 specific immune responses. Vet Immunol Immunopathol. 2014;161(3–4):193–204. https://doi.org/10.1016/j.vetimm.2014.08.010.CrossRefPubMed

64.

Arafa MG, Ghalwash D, El-Kersh DM, Elmazar MM. Propolis-based niosomes as oromuco-adhesive films: a randomized clinical trial of a therapeutic drug delivery platform for the treatment of oral recurrent aphthous ulcers. Sci Rep. 2018;8(1):18056. https://doi.org/10.1038/s41598-018-37157-7.CrossRefPubMedPubMedCentral

65.

Mohammadinejad S, Akbarzadeh A, Rahmati M, Hatam S, Kachalaki S, Sanaat Z, et al. Preparation and evaluation of chrysin encapsulated in PLGA- PEG nanoparticles in the T47-D breast cancer cell line. Asian Pac J Cancer Prev. 2015;16:3753–8. https://doi.org/10.7314/apjcp.2015.16.9.3753.CrossRefPubMed

66.

Bagheri R, Sanaat Z, Zarghami N. Synergistic effect of free and nano-encapsulated chrysin-curcumin on inhibition of hTERT gene expression in SW480 colorectal cancer cell line. Drug Res. 2018;68(6):335–43. https://doi.org/10.1055/s-0043-121338.CrossRef

67.

Zheng H, Li S, Pu Y, Lai Y, He B, Gu Z. Nanoparticles generated by PEG-Chrysin conjugates for efficient anticancer drug delivery. Eur J Pharm Biopharm. 2014;87(3):454–60. https://doi.org/10.1016/j.ejpb.2014.03.011.CrossRefPubMed

68.

Sabzichi M, Mohammadian J, Bazzaz R, Pirouzpanah MB, Shaaker M, Hamishehkar H, et al. Chrysin loaded nanostructured lipid carriers (NLCs) triggers apoptosis in MCF-7 cancer cells by inhibiting the Nrf2 pathway. Process Biochem. 2017;60:84–91. https://doi.org/10.1016/j.procbio.2017.05.024.CrossRef

69.

Liang Y, Peng X, Chen Y, Deng X, Gao W, Cao J, et al. Chain length effect on drug delivery of chrysin modified mPEG–PCL micelles. RSC Adv. 2015;5(73):59014–21. https://doi.org/10.1039/C5RA09650B.CrossRef

70.

Davaran S, Fazeli H, Ghamkhari A, Rahimi F, Molavi O, Anzabi M, et al. Synthesis and characterization of novel P(HEMA-LA-MADQUAT) micelles for co-delivery of methotrexate and chrysin in combination cancer chemotherapy. J Biomater Sci Polym Ed. 2018;29(11):1265–86. https://doi.org/10.1080/09205063.2018.1456026.CrossRefPubMed

71.

Dhawan K, Kumar S, Sharma A. Beneficial effects of chrysin and benzoflavone on virility in 2-year-old male rats. J Med Food. 2002;5(1):43–8. https://doi.org/10.1089/109662002753723214.CrossRefPubMed

72.

Tobin PJ, Beale P, Noney L, Liddell S, Rivory LP, Clarke S. A pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irinotecan (CPT-11) to treat metastatic colorectal cancer. Cancer Chemother Pharmacol. 2006;57(3):309–16. https://doi.org/10.1007/s00280-005-0053-0.CrossRefPubMed

73.

Naz S, Imran M, Rauf A, Orhan IE, Shariati MA, Iahtisham Ul H, et al. Chrysin: pharmacological and therapeutic properties. Life Sci. 2019;235:116797. https://doi.org/10.1016/j.lfs.2019.116797.CrossRefPubMed

74.

Gardner I, Popović M, Zahid N, Uetrecht JP. A comparison of the covalent binding of clozapine, procainamide, and vesnarinone to human neutrophils in vitro and rat tissues in vitro and in vivo. Chem Res Toxicol. 2005;18(9):1384–94. https://doi.org/10.1021/tx050095o.CrossRefPubMed

75.

Kim KM, Jung J. Upregulation of G protein-coupled estrogen receptor by chrysin-nanoparticles inhibits tumor proliferation and metastasis in triple negative breast cancer xenograft model. Front Endocrinol. 2020;11. https://doi.org/10.3389/fendo.2020.560605.

76.

Nagasaka M, Hashimoto R, Inoue Y, Ishiuchi K, Matsuno M, Itoh Y, et al. Anti-tumorigenic activity of chrysin from oroxylum indicum via non-genotoxic p53 activation through the ATM-Chk2 pathway. Molecules. 2018;23(6):1394. https://doi.org/10.3390/molecules23061394.CrossRefPubMedCentral

77.

Rasouli S, Zarghami N. Synergistic growth inhibitory effects of chrysin and metformin combination on breast cancer cells through hTERT and cyclin D1 suppression. Asian Pac J Cancer Prev. 2018;19(4):977–82. https://doi.org/10.22034/APJCP.2018.19.4.977.CrossRefPubMedPubMedCentral

78.

Javan Maasomi Z, Pilehvar Soltanahmadi Y, Dadashpour M, Alipour S, Abolhasani S, Zarghami N. Synergistic anticancer effects of silibinin and chrysin in T47D breast cancer cells. Asian Pac J Cancer Prev. 2017;18(5):1283–7. https://doi.org/10.22034/APJCP.2017.18.5.1283.CrossRefPubMed

79.

Samarghandian S, Azimi-Nezhad M, Borji A, Hasanzadeh M, Jabbari F, Farkhondeh T, et al. Inhibitory and cytotoxic activities of chrysin on human breast adenocarcinoma cells by induction of apoptosis. Pharmacogn Mag. 2016;12(Suppl 4):S436–40. https://doi.org/10.4103/0973-1296.191453.CrossRefPubMedPubMedCentral

80.

Yang B, Huang J, Xiang T, Yin X, Luo X, Huang J, et al. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway. J Appl Toxicol. 2014;34(1):105–12. https://doi.org/10.1002/jat.2941.CrossRefPubMed

81.

Ding J, Polier G, Koḧler R, Giaisi M, Krammer PH, Li-Weber M. Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression. J Biol Chem. 2012;287(1):641–9. https://doi.org/10.1074/jbc.M111.286526.CrossRefPubMed

82.

Sassa-Deepaeng T, Chaisri W, Pikulkaew S, Okonogi S. Investigation of antiaromatase activity using hepatic microsomes of Nile tilapia (Oreochromis niloticus). Drug Discov Ther. 2017;11(2):84–90. https://doi.org/10.5582/ddt.2017.01006.CrossRefPubMed

83.

Hong TB, Rahumatullah A, Yogarajah T, Ahmad M, Yin KB. Potential effects of chrysin on MDA-MB-231 cells. Int J Mol Sci. 2010;11(3):1057–69. https://doi.org/10.3390/ijms11031057.CrossRefPubMedPubMedCentral

84.

Manupati K, Dhoke NR, Debnath T, Yeeravalli R, Guguloth K, Saeidpour S, et al. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs. FEBS J. 2017;284(12):1830–54. https://doi.org/10.1111/febs.14084.CrossRefPubMed

85.

Xuan HZ, Zhang JH, Wang YH, Fu CL, Zhang W. Anti-tumor activity evaluation of novel chrysin-organotin compound in MCF-7 cells. Bioorg Med Chem Lett. 2016;26(2):570–4. https://doi.org/10.1016/j.bmcl.2015.11.072.CrossRefPubMed

86.

Roy S, Sil A, Chakraborty T. Potentiating apoptosis and modulation of p53, Bcl2, and Bax by a novel chrysin ruthenium complex for effective chemotherapeutic efficacy against breast cancer. J Cell Physiol. 2019;234(4):4888–909. https://doi.org/10.1002/jcp.27287.CrossRefPubMed

87.

Zhang S, Yang X, Morris ME. Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol Pharmacol. 2004;65(5):1208–16. https://doi.org/10.1124/mol.65.5.1208.CrossRefPubMed

88.

Cao XZ, Xiang HL, Quan MF, He LH. Inhibition of cell growth by BrMC through inactivation of Akt in HER-2/neu-overexpressing breast cancer cells. Oncol Lett. 2014;7(5):1632–8. https://doi.org/10.3892/ol.2014.1889.CrossRefPubMedPubMedCentral

89.

Zhao XC, Cao XC, Liu F, Quan MF, Ren KQ, Cao JG. Regulation of the FOXO3a/bim signaling pathway by 5,7-dihydroxy-8-nitrochrysin in MDA-MB-453 breast cancer cells. Oncol Lett. 2013;5(3):929–34. https://doi.org/10.3892/ol.2012.1077.CrossRefPubMed

90.

Al-Oudat BA, Alqudah MA, Audat SA, Al-Balas QA, El-Elimat T, Hassan MA, et al. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators. Drug Des Devel Ther. 2019;13:423–33. https://doi.org/10.2147/DDDT.S189476.CrossRefPubMedPubMedCentral

91.

Gnanasekar S, Balakrishnan D, Seetharaman P, Arivalagan P, Chandrasekaran R, Sivaperumal S. Chrysin-anchored silver and gold nanoparticle-reduced graphene oxide composites for breast cancer therapy. ACS Appl Nano Mater. 2020;3(5):4574–85. https://doi.org/10.1021/acsanm.0c00630.CrossRef

92.

Eatemadi A, Daraee H, Aiyelabegan HT, Negahdari B, Rajeian B, Zarghami N. Synthesis and characterization of chrysin-loaded PCL-PEG-PCL nanoparticle and its effect on breast cancer cell line. Biomed Pharmacother. 2016;84:1915–22. https://doi.org/10.1016/j.biopha.2016.10.095.CrossRefPubMed

93.

Zhong X, Liu D, Jiang Z, Li C, Chen L, Xia Y, et al. Chrysin induced cell apoptosis and inhibited invasion through regulation of TET1 expression in gastric cancer cells. Onco Targets Ther. 2020;13:3277–87. https://doi.org/10.2147/OTT.S302177.CrossRefPubMedPubMedCentral

94.

Mohammadian F, Pilehvar-Soltanahmadi Y, Alipour S, Dadashpour M, Zarghami N. Chrysin alters microRNAs expression levels in gastric cancer cells: possible molecular mechanism. Drug Res. 2017;67(9):509–14. https://doi.org/10.1055/s-0042-119647.CrossRef

95.

Mohammadian F, Abhari A, Dariushnejad H, Nikanfar A, Pilehvar-Soltanahmadi Y, Zarghami N. Effects of chrysin-PLGA-PEG nanoparticles on proliferation and gene expression of mirnas in gastric cancer cell line. Int J Cancer Manag. 2016;9(4). https://doi.org/10.17795/ijcp-4190.

96.

Mohammadian F, Pilehvar-Soltanahmadi Y, Zarghami F, Akbarzadeh A, Zarghami N. Upregulation of miR-9 and Let-7a by nanoencapsulated chrysin in gastric cancer cells. Artif Cells Nanomed Biotechnol. 2017;45(6):1201–6. https://doi.org/10.1080/21691401.2016.1216854.CrossRef

97.

Mohammadian F, Pilehvar-Soltanahmadi Y, Mofarrah M, Dastani-Habashi M, Zarghami N. Down regulation of miR-18a, miR-21 and miR-221 genes in gastric cancer cell line by chrysin-loaded PLGA-PEG nanoparticles. Artif Cells Nanomed Biotechnol. 2016;44(8):1972–8. https://doi.org/10.3109/21691401.2015.1129615.CrossRefPubMed

98.

Xia Y, Lian S, Khoi PN, Yoon HJ, Joo YE, Chay KO, et al. Chrysin inhibits tumor promoter-induced MMP-9 expression by blocking AP-1 via suppression of ERK and JNK pathways in gastric cancer cells. PLoS ONE. 2015;10(4). https://doi.org/10.1371/journal.pone.0124007.

99.

Xia Y, Lian S, Khoi PN, Yoon HJ, Han JY, Chay KO, et al. Chrysin inhibits cell invasion by inhibition of Recepteur d’origine Nantais via suppressing early growth response-1 and NF-κB transcription factor activities in gastric cancer cells. Int J Oncol. 2015;46(4):1835–43. https://doi.org/10.3892/ijo.2015.2847.CrossRefPubMed

100.

Bakhsheshian J, Hall MD, Robey RW, Herrmann MA, Chen JQ, Bates SE, et al. Overlapping substrate and inhibitor specificity of human and murine ABCG2. Drug Metab Dispos. 2013;41(10):1805–12. https://doi.org/10.1124/dmd.113.053140.CrossRefPubMedPubMedCentral

101.

Wang Z, Deng X, Xiong S, Xiong R, Liu J, Zou L, et al. Design, synthesis and biological evaluation of chrysin benzimidazole derivatives as potential anticancer agents. Nat Prod Res. 2018;32(24):2900–9. https://doi.org/10.1080/14786419.2017.1389940.CrossRefPubMed

102.

Ai XH, Zheng X, Tang XQ, Sun L, Zhang YQ, Qin Y, et al. Induction of apoptosis of human gastric carcinoma SGC-7901 cell line by 5, 7-dihydroxy-8-nitrochrysin in vitro. World J Gastroenterol. 2007;13(28):3824–8. https://doi.org/10.3748/wjg.v13.i28.3824.CrossRefPubMedPubMedCentral

103.

Lee S, Lee SK, Jung J. Potentiating activities of chrysin in the therapeutic efficacy of 5-fluorouracil in gastric cancer cells. Oncol Lett. 2021;21(1):1–7. https://doi.org/10.3892/ol.2020.12285.CrossRef

104.

Xiang HL, Zheng X, Cao JG. Induction of apoptosis of human gastric carcinoma SGC-7901 cell line by 8-bromo-7-methoxychrysin. Chin Pharmacol Bull. 2008;24(10):1370–2.

105.

Liu Y, Song X, Ma J, He J, Zheng X, Lei X, et al. Synthesis of new 7-O-modified chrysin derivatives and their anti-proliferative and apoptotic effects on human gastric carcinoma MGC-803 cells. Chem Res Chin Univ. 2014;30(6):925–30. https://doi.org/10.1007/s40242-014-4269-6.CrossRef

106.

Araújo JR, Gonçalves P, Martel F. Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr Res. 2011;31(2):77–87. https://doi.org/10.1016/j.nutres.2011.01.006.CrossRefPubMed

107.

Lin YM, Chen CI, Hsiang YP, Hsu YC, Cheng KC, Chien PH, et al. Chrysin attenuates cell viability of human colorectal cancer cells through autophagy induction unlike 5-fluorouracil/oxaliplatin. Int J Mol Sci. 2018;19(6). https://doi.org/10.3390/ijms19061763.

108.

Ronnekleiv-Kelly SM, Nukaya M, Díaz-Díaz CJ, Megna BW, Carney PR, Geiger PG, et al. Aryl hydrocarbon receptor-dependent apoptotic cell death induced by the flavonoid chrysin in human colorectal cancer cells. Cancer Lett. 2016;370(1):91–9. https://doi.org/10.1016/j.canlet.2015.10.014.CrossRefPubMed

109.

Bahadori M, Baharara J, Amini E. Anticancer properties of chrysin on colon cancer cells, in vitro and in vivo with modulation of caspase-3, -9, Bax and sall4. Iran J Biotechnol. 2016;14(3):177–84. https://doi.org/10.15171/IJB.1374.CrossRefPubMedPubMedCentral

110.

Schumacher M, Hautzinger A, Rossmann A, Holzhauser S, Popovic D, Hertrampf A, et al. Chrysin blocks topotecan-induced apoptosis in Caco-2 cells in spite of inhibition of ABC-transporters. Biochem Pharmacol. 2010;80(4):471–9. https://doi.org/10.1016/j.bcp.2010.04.038.CrossRefPubMed

111.

Romier B, Van De Walle J, During A, Larondelle Y, Schneider YJ. Modulation of signalling nuclear factor-kappaB activation pathway by polyphenols in human intestinal Caco-2 cells. Br J Nutr. 2008;100(3):542–51. https://doi.org/10.1017/S0007114508966666.CrossRefPubMed

112.

León IE, Cadavid-Vargas JF, Tiscornia I, Porro V, Castelli S, Katkar P, et al. Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model. J Biol Inorg Chem. 2015;20(7):1175–91. https://doi.org/10.1007/s00775-015-1298-7.CrossRefPubMed

113.

Choi JK, Jang YH, Lee S, Lee SR, Choi YA, Jin M, et al. Chrysin attenuates atopic dermatitis by suppressing inflammation of keratinocytes. Food Chem Toxicol. 2017;110:142–50. https://doi.org/10.1016/j.fct.2017.10.025.CrossRefPubMed

114.

Galijatovic A, Otake Y, Walle UK, Walle T. Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells–potential role in carcinogen bioinactivation. Pharm Res. 2001;18(3):374–9. https://doi.org/10.1023/a:1011019417236.CrossRefPubMed

115.

Bhardwaj M, Kim NH, Paul S, Jakhar R, Han J, Kang SC. 5-Hydroxy-7-methoxyflavone triggers mitochondrial-associated cell death via reactive oxygen species signaling in human colon carcinoma cells. PLoS ONE. 2016;11(4). https://doi.org/10.1371/journal.pone.0154525.

116.

Salama AAA, Allam RM. Promising targets of chrysin and daidzein in colorectal cancer: amphiregulin, CXCL1, and MMP-9. Eur J Pharmacol. 2021;892. https://doi.org/10.1016/j.ejphar.2020.173763.

117.

Ren J, Cheng H, Xin WQ, Chen X, Hu K. Induction of apoptosis by 7-piperazinethylchrysin in HCT-116 human colon cancer cells. Oncol Rep. 2012;28(5):1719–26. https://doi.org/10.3892/or.2012.2016.CrossRefPubMed

118.

Khoo BY, Chua SL, Balaram P. Apoptotic effects of chrysin in human cancer cell lines. Int J Mol Sci. 2010;11(5). https://doi.org/10.3390/ijms11052188.

119.

Zhang Q, Zhao XH, Wang ZJ. Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. Toxicol In Vitro. 2009;23(5):797–807. https://doi.org/10.1016/j.tiv.2009.04.007.CrossRefPubMed

120.

Zhang Q, Zhao XH, Wang ZJ. Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem Toxicol. 2008;46(6):2042–53. https://doi.org/10.1016/j.fct.2008.01.049.CrossRefPubMed

121.

Wang ZJ, Zhang Q, Li TJ, Zhao XH. A possible molecular mechanism of two flavones and two flavonols on the induction of differentiation in a human oesophageal adenocarcinoma cell line (OE33). J Med Plant Res. 2011;5(13):2652–64.

122.

Zhang Q, Zhao XH. Molecular mechanism of flavones and flavonols on the induction of cell cycle arrest in human esophageal carcinoma cells. Prog Biochem Biophys. 2008;35(9):1031–8.

123.

Celińska-Janowicz K, Zaręba I, Lazarek U, Teul J, Tomczyk M, Pałka J, et al. Constituents of propolis: chrysin, caffeic acid, p-coumaric acid, and ferulic acid Induce PRODH/POX-dependent apoptosis in human tongue squamous cell carcinoma cell (CAL-27). Front Pharmacol. 2018;9:336. https://doi.org/10.3389/fphar.2018.00336.CrossRefPubMedPubMedCentral

124.

Xie Y, Peng X (2019). Effects of chrysin on the apoptosis in oral squamous carcinoma kb cell line and the underlying mechanisms. J Cent South Univ Med Sci. 2019;44(5):522–7. Doi: https://doi.org/10.11817/j.issn.1672-7347.2019.05.008.

125.

Bishayee A, Thoppil RJ, Waghray A, Kruse JA, Novotny NA, Darvesh AS. Dietary phytochemicals in the chemoprevention and treatment of hepatocellular carcinoma: in vivo evidence, molecular targets, and clinical relevance. Curr Cancer Drug Targets. 2012;12(9):1191–232. https://doi.org/10.2174/15680096112091191.CrossRefPubMed

126.

Zhang Y, Chen F, Xiao X, Pan W, Yuan Q, Cao J. Chrysin inhibits sphere formation in SMMC-7721 cells via modulation of SHP-1/STAT3 signaling pathway. Cancer Manag Res. 2019;11:2977–85. https://doi.org/10.2147/CMAR.S193647.CrossRefPubMedPubMedCentral

127.

Wei CT, Chen LC, Hsiang YP, Hung YJ, Chien PH, Pan HL, et al. Chrysin-induced ERK1/2 phosphorylation enhances the sensitivity of human hepatocellular carcinoma cells to sorafenib. Anticancer Res. 2019;39(2):695–701. https://doi.org/10.21873/anticanres.13165.CrossRefPubMed

128.

Seydi E, Rahimpour Z, Salimi A, Pourahmad J. Selective toxicity of chrysin on mitochondria isolated from liver of a HCC rat model. Bioorg Med Chem. 2019;27(24):115163. https://doi.org/10.1016/j.bmc.2019.115163.CrossRefPubMed

129.

Xu D, Jin J, Yu H, Zhao Z, Ma D, Zhang C, et al. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2. J Exp Clin Cancer Res. 2017;36(1):44. https://doi.org/10.1186/s13046-017-0514-4.CrossRefPubMedPubMedCentral

130.

Zhang Q, Ma S, Liu B, Liu J, Zhu R, Li M. Chrysin induces cell apoptosis via activation of the p53/Bcl-2/caspase-9 pathway in hepatocellular carcinoma cells. Exp Ther Med. 2016;12(1):469–74. https://doi.org/10.3892/etm.2016.3282.CrossRefPubMedPubMedCentral

131.

Li X, Huang JM, Wang JN, Xiong XK, Yang XF, Zou F. Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53. Chem Biol Interact. 2015;232:12–20. https://doi.org/10.1016/j.cbi.2015.03.003.CrossRefPubMed

132.

Oliveira GA, Ferraz ER, Souza AO, Lourenço RA, Oliveira DP, Dorta DJ. Evaluation of the mutagenic activity of chrysin, a flavonoid inhibitor of the aromatization process. J Toxicol Environ Health Part A. 2012;75(16–17):1000–11. https://doi.org/10.1080/15287394.2012.696517.CrossRef

133.

Gao AM, Ke ZP, Shi F, Sun GC, Chen H. Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway. Chem Biol Interact. 2013;206(1):100–8. https://doi.org/10.1016/j.cbi.2013.08.008.CrossRefPubMed

134.

Talebi M, Talebi M, Farkhondeh T, Mishra G, İlgün S, Samarghandian S. New insights into the role of the Nrf2 signaling pathway in green tea catechin applications. Phytother Res. 2021. https://doi.org/10.1002/ptr.7033.CrossRefPubMed

135.

Sun X, Huo X, Luo T, Li M, Yin Y, Jiang Y. The anticancer flavonoid chrysin induces the unfolded protein response in hepatoma cells. J Cell Mol Med. 2011;15(11):2389–98. https://doi.org/10.1111/j.1582-4934.2010.01244.x.CrossRefPubMedPubMedCentral

136.

Khan MS, Devaraj H, Devaraj N. Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats. Toxicol Appl Pharmacol. 2011;251(1):85–94. https://doi.org/10.1016/j.taap.2010.12.004.CrossRefPubMed

137.

Walle T, Otake Y, Galijatovic A, Ritter JK, Walle UK. Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line hep G2. Drug Metab Dispos. 2000;28(9):1077–82.PubMed

138.

Sherif IO, Al-Mutabagani LA, Sabry D, Elsherbiny NM. Antineoplastic activity of chrysin against human hepatocellular carcinoma: new insight on gpc3/sulf2 axis and lncrna-af085935 expression. Int J Mol Sci. 2020;21(20):1–14. https://doi.org/10.3390/ijms21207642.CrossRef

139.

Wang ZP, Zhou Q, Shi HZ, Xiong S, Wang YF. Anti-hepatocarcinoma effects of a food additive chrysin nanosuspension against human HepG2 cells. Adv J Food Sci Technol. 2015;7(8):627–30.CrossRef

140.

Khan MS, Halagowder D, Devaraj SN. Methylated chrysin induces co-ordinated attenuation of the canonical Wnt and NF-kB signaling pathway and upregulates apoptotic gene expression in the early hepatocarcinogenesis rat model. Chem Biol Interact. 2011;193(1):12–21. https://doi.org/10.1016/j.cbi.2011.04.007.CrossRefPubMed

141.

Yang XH, Zheng X, Cao JG, Xiang HL, Liu F, Lv Y. 8-bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK. World J Gastroenterol. 2010;16(27):3385–93. https://doi.org/10.3748/wjg.v16.i27.3385.CrossRefPubMedPubMedCentral

142.

Rashid S, Nafees S, Vafa A, Afzal SM, Ali N, Rehman MU, et al. Inhibition of precancerous lesions development in kidneys by chrysin via regulating hyperproliferation, inflammation and apoptosis at pre clinical stage. Arch Biochem Biophys. 2016;606:1–9. https://doi.org/10.1016/j.abb.2016.07.004.CrossRefPubMed

143.

Rehman MU, Tahir M, Khan AQ, Khan R, Lateef A, Oday OH, et al. Chrysin suppresses renal carcinogenesis via amelioration of hyperproliferation, oxidative stress and inflammation: plausible role of NF-κB. Toxicol Lett. 2013;216(2–3):146–58. https://doi.org/10.1016/j.toxlet.2012.11.013.CrossRefPubMed

144.

Xu Y, Tong Y, Ying J, Lei Z, Wan L, Zhu X, et al. Chrysin induces cell growth arrest, apoptosis, and ER stress and inhibits the activation of STAT3 through the generation of ROS in bladder cancer cells. Oncol Lett. 2018;15(6):9117–25. https://doi.org/10.3892/ol.2018.8522.CrossRefPubMedPubMedCentral

145.

Lima APB, Almeida TC, Barros TMB, Rocha LCM, Garcia CCM, da Silva GN. Toxicogenetic and antiproliferative effects of chrysin in urinary bladder cancer cells. Mutagenesis. 2020. https://doi.org/10.1093/mutage/geaa021.CrossRefPubMed

146.

Talebi M, Talebi M, Kakouri E, Farkhondeh T, Pourbagher-Shahri AM, Tarantilis PA, et al. Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases. Int J Biol Macromol. 2021;172:93–103. https://doi.org/10.1016/j.ijbiomac.2021.01.042.CrossRefPubMed

147.

Szliszka E, Gebka J, Bronikowska J, Krol W. Dietary flavones enhance the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on bladder cancer cells. Cent European J Urol. 2010;63(3):138–43.CrossRef

148.

Oršolić N, Štajcar D, Bašić I. Propolis and its flavonoid compounds cause cytotoxicity on human urinary bladder transitional cell carcinoma in primary culture. Period Biol. 2009;111(1):113–21.

149.

Sak K, Lust H, Kase M, Saar M, Jaal J. Suppression of taxanes cytotoxicity by citrus flavonoid hesperetin in PPC-1 human prostate cancer cells. Anticancer Res. 2018;38(11):6209–15. https://doi.org/10.21873/anticanres.12975.CrossRefPubMed

150.

Ryu S, Lim W, Bazer FW, Song G. Chrysin induces death of prostate cancer cells by inducing ROS and ER stress. J Cell Physiol. 2017;232(12):3786–97. https://doi.org/10.1002/jcp.25861.CrossRefPubMed

151.

Samarghandian S, Afshari JT, Davoodi S. Chrysin reduces proliferation and induces apoptosis in the human prostate cancer cell line pc-3. Clinics (Sao Paulo). 2011;66(6):1073–9. https://doi.org/10.1590/S1807-59322011000600026.CrossRef

152.

Abel SDA, Dadhwal S, Gamble AB, Baird SK. Honey reduces the metastatic characteristics of prostate cancer cell lines by promoting a loss of adhesion. PeerJ. 2018;2018(7). https://doi.org/10.7717/peerj.5115.

153.

Fu B, Xue J, Li Z, Shi X, Jiang BH, Fang J. Chrysin inhibits expression of hypoxia-inducible factor 1-α through reducing hypoxia-inducible factor-1α stability and inhibiting its protein synthesis. Mol Cancer Ther. 2007;6(1):220–6. https://doi.org/10.1158/1535-7163.MCT-06-0526.CrossRefPubMed

154.

Szliszka E, Sokół-Łętowska A, Kucharska AZ, Jaworska D, Czuba ZP, Król W. Ethanolic extract of polish propolis: chemical composition and TRAIL-R2 death receptor targeting apoptotic activity against prostate cancer cells. Evid Based Complement Alternat Med. 2013;2013:757628. https://doi.org/10.1155/2013/757628.CrossRefPubMedPubMedCentral

155.

Li H, Chen A, Yuan Q, Chen W, Zhong H, Teng M, et al. NF-κB/Twist axis is involved in chysin inhibition of ovarian cancer stem cell features induced by co-treatment of TNF-α and TGF-β. Int J Clin Exp Pathol. 2019;12(1):101–12.PubMedPubMedCentral

156.

Lim W, Ryu S, Bazer FW, Kim SM, Song G. Chrysin attenuates progression of ovarian cancer cells by regulating signaling cascades and mitochondrial dysfunction. J Cell Physiol. 2018;233(4):3129–40. https://doi.org/10.1002/jcp.26150.CrossRefPubMed

157.

Pourbagher-Shahri AM, Farkhondeh T, Ashrafizadeh M, Talebi M, Samargahndian S. Curcumin and cardiovascular diseases: focus on cellular targets and cascades. Biomed Pharmacother. 2021;136:111214. https://doi.org/10.1016/j.biopha.2020.111214.CrossRefPubMed

158.

Li H, Chen Y, Fang Y, Zhong L, Yuan Q, Xu X, et al. Effects of chrysin on sphere formation and CK2α expression of ovarian cancer stem-like cells derived from SKOV3 cell line. Natl Med J Chin. 2016;96(25):2013–6. https://doi.org/10.3760/cma.j.issn.0376-2491.2016.25.012.CrossRef

159.

Ding Q, Chen Y, Zhang Q, Guo Y, Huang Z, Dai L, et al. 8-Bromo-7-methoxychrysin induces apoptosis by regulating Akt/FOXO3a pathway in cisplatin-sensitive and resistant ovarian cancer cells. Mol Med Rep. 2015;12(4):5100–8. https://doi.org/10.3892/mmr.2015.4039.CrossRefPubMedPubMedCentral

160.

Santos I, Ramos C, Mendes C, Sequeira CO, Tomé CS, Fernandes DGH, et al. Targeting glutathione and cystathionine β-synthase in ovarian cancer treatment by selenium–chrysin polyurea dendrimer nanoformulation. Nutrients. 2019;11(10). https://doi.org/10.3390/nu11102523.

161.

Li HZ, Cao JG, Deng YA, Xu JH, Xie WY. Induction of apoptosis of human ovarian cancer CoC1 cells by 5-Allyl-7-Gen-difluoromethylenechrysin through activation of peroxisome-proliferator activated receptor-gamma. Natl Med J Chin. 2007;87(41):2914–8.

162.

Qiu HZ, Huang J, Xiang CC, Li R, Zuo ED, Zhang Y, et al. Screening and discovery of new potential biomarkers and small molecule drugs for cervical cancer: a bioinformatics analysis. Technol Cancer Res Treat. 2020;19. https://doi.org/10.1177/1533033820980112.

163.

Wahab NH, Mat NFC. Baicalein-rich fraction of Oroxylum indicum leaves induces apoptosis by repressing E6 and E7 expression in HPV-associated cervical cancer cell lines. Int J Res Pharm Sci. 2018;9(Special issue 2):108–17. https://doi.org/10.26452/ijrps.v9iSPL2.1751.CrossRef

164.

Dong W, Chen A, Chao X, Li X, Cui Y, Xu C, et al. Chrysin inhibits proinflammatory factor-induced EMT phenotype and cancer stem cell-like features in HeLa cells by blocking the NF-κB/Twist axis. Cell Physiol Biochem. 2019;52(5):1236–50. https://doi.org/10.33594/000000084.CrossRefPubMed

165.

Feinshtein V, Holcberg G, Amash A, Erez N, Rubin M, Sheiner E, et al. Nitrofurantoin transport by placental choriocarcinoma JAr cells: involvement of BCRP, OATP2B1 and other MDR transporters. Arch Gynecol Obstet. 2010;281(6):1037–44. https://doi.org/10.1007/s00404-009-1286-7.CrossRefPubMed

166.

Park W, Park S, Lim W, Song G. Chrysin disrupts intracellular homeostasis through mitochondria-mediated cell death in human choriocarcinoma cells. Biochem Biophys Res Commun. 2018;503(4):3155–61. https://doi.org/10.1016/j.bbrc.2018.08.109.CrossRefPubMed

167.

Talebi M, Talebi M, Samarghandian S. Association of Crocus sativus with cognitive dysfunctions and Alzheimer’s disease: a systematic review. Biointerface Res Appl Chem. 2021. https://doi.org/10.33263/BRIAC111.74687492.

168.

Araújo JR, Gonçalves P, Martel F. Modulation of glucose uptake in a human choriocarcinoma cell line (BeWo) by dietary bioactive compounds and drugs of abuse. J Biochem. 2008;144(2):177–86. https://doi.org/10.1093/jb/mvn054.CrossRefPubMed

169.

Li D, Li L, Wang L, Li J, Zhang B. 7-Piperazine ethyl chrysin inhibits proliferation of lung cancer cells via induction of apoptosis. Trop J Pharm Res. 2018;17(10):1919–24. https://doi.org/10.4314/tjpr.v17i10.4.CrossRef

170.

Maruhashi R, Eguchi H, Akizuki R, Hamada S, Furuta T, Matsunaga T, et al. Chrysin enhances anticancer drug-induced toxicity mediated by the reduction of claudin-1 and 11 expression in a spheroid culture model of lung squamous cell carcinoma cells. Sci Rep. 2019;9(1):13753. https://doi.org/10.1038/s41598-019-50276-z.CrossRefPubMedPubMedCentral

171.

Wu TC, Chan ST, Chang CN, Yu PS, Chuang CH, Yeh SL. Quercetin and chrysin inhibit nickel-induced invasion and migration by downregulation of TLR4/NF-κB signaling in A549 cells. Chem Biol Interact. 2018;292:101–9. https://doi.org/10.1016/j.cbi.2018.07.010.CrossRefPubMed

172.

Samarghandian S, Nezhad MA, Mohammadi G. Role of caspases, Bax and Bcl-2 in chrysin-induced apoptosis in the A549 human lung adenocarcinoma epithelial cells. Anticancer Agents Med Chem. 2014;14(6):901–9. https://doi.org/10.2174/1871520614666140209144042.CrossRefPubMed

173.

Kasala ER, Bodduluru LN, Barua CC, Madhana RM, Dahiya V, Budhani MK, et al. Chemopreventive effect of chrysin, a dietary flavone against benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice. Pharmacol Rep. 2016;68(2):310–8. https://doi.org/10.1016/j.pharep.2015.08.014.CrossRefPubMed

174.

Shao JJ, Zhang AP, Qin W, Zheng L, Zhu YF, Chen X. AMP-activated protein kinase (AMPK) activation is involved in chrysin-induced growth inhibition and apoptosis in cultured A549 lung cancer cells. Biochem Biophys Res Commun. 2012;423(3):448–53. https://doi.org/10.1016/j.bbrc.2012.05.123.CrossRefPubMed

175.

Brechbuhl HM, Kachadourian R, Min E, Chan D, Day BJ. Chrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: the role of glutathione. Toxicol Appl Pharmacol. 2012;258(1):1–9. https://doi.org/10.1016/j.taap.2011.08.004.CrossRefPubMed

176.

Wang HW, Lin CP, Chiu JH, Chow KC, Kuo KT, Lin CS, et al. Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin. Int J Cancer. 2007;120(9):2019–27. https://doi.org/10.1002/ijc.22402.CrossRefPubMed

177.

Shin H-D, Lee HJ, Sikder M, Park SH, Ryu J, Hong J-H, et al. Effect of chrysin on gene expression and production of MUC5AC mucin from cultured airway epithelial cells. Tuberc Respir Dis (Seoul). 2012;73(4):204–9. https://doi.org/10.4046/trd.2012.73.4.204.CrossRef

178.

Sharifi-Rad J, Rajabi S, Martorell M, López MD, Toro MT, Barollo S, et al. Plant natural products with anti-thyroid cancer activity. Fitoterapia. 2020;146:104640. https://doi.org/10.1016/j.fitote.2020.104640.CrossRefPubMed

179.

Granata R, Locati L, Licitra L. Therapeutic strategies in the management of patients with metastatic anaplastic thyroid cancer: review of the current literature. Curr Opin Oncol. 2013;25(3):224–8. https://doi.org/10.1097/CCO.0b013e32835ff44b.CrossRefPubMed

180.

Yu XM, Phan T, Patel PN, Jaskula-Sztul R, Chen H. Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo. Cancer. 2013;119(4):774–81. https://doi.org/10.1002/cncr.27742.CrossRefPubMed

181.

Zhang C, Yu M, Hao F, Dong A, Chen D, Zhang K. Chrysin inhibits growth and induces apoptosis of anaplastic thyroid cancer cells via Notch-1/Slug/PUMA signals. Int J Clin Exp Pathol. 2016;9(9):9038–47.

182.

Phan T, Yu XM, Kunnimalaiyaan M, Chen H. Antiproliferative effect of chrysin on anaplastic thyroid cancer. J Surg Res. 2011;170(1):84–8. https://doi.org/10.1016/j.jss.2011.03.064.CrossRefPubMedPubMedCentral

183.

Wei Y, Zheng Q, Tang G, Song C, Wang G, Zhang Y, et al. Synthesis and anti-thyroid cancer effect of iodo-chrysin derivatives. Med Chem. 2016;12(5):441–7. https://doi.org/10.2174/1573406411666150921111220.CrossRefPubMed

184.

Wang Z, Liang T, Li T, Zhou K. Effect of chrysin in inhibiting proliferation of human nasopharyngeal carcinoma cell line CNE-2. J Chin Pharma Univ. 2013;44(1):93–6.

185.

Syed DN, Mukhtar H. Botanicals for the prevention and treatment of cutaneous melanoma. Pigment Cell Melanoma Res. 2011;24(4):688–702. https://doi.org/10.1111/j.1755-148X.2011.00851.x.CrossRefPubMedPubMedCentral

186.

Benguedouar L, Lahouel M, Gangloff SC, Durlach A, Grange F, Bernard P, et al. Ethanolic extract of Algerian propolis and galangin decreased murine melanoma T. Anticancer Agents Med Chem. 2016;16(9):1172–83. https://doi.org/10.2174/1871520616666160211124459.CrossRefPubMed

187.

Chen HY, Jiang YW, Kuo CL, Way TD, Chou YC, Chang YS, et al. Chrysin inhibit human melanoma A375.S2 cell migration and invasion via affecting MAPK signaling and NF-κB signaling pathway in vitro. Environ Toxicol. 2019;34(4):434–42. https://doi.org/10.1002/tox.22697.CrossRefPubMed

188.

Sassi A, Maatouk M, El Gueder D, Bzéouich IM, Abdelkefi-Ben Hatira S, Jemni-Yacoub S, et al. Chrysin, a natural and biologically active flavonoid suppresses tumor growth of mouse B16F10 melanoma cells: in vitro and in vivo study. Chem Biol Interact. 2018;283:10–9. https://doi.org/10.1016/j.cbi.2017.11.022.CrossRefPubMed

189.

Pal-Bhadra M, Ramaiah MJ, Reddy TL, Krishnan A, Pushpavalli SNCVL, Babu KS, et al. Plant HDAC inhibitor chrysin arrest cell growth and induce p21WAF1 by altering chromatin of STAT response element in A375 cells. BMC Cancer. 2012;12. https://doi.org/10.1186/1471-2407-12-180.

190.

Pichichero E, Cicconi R, Mattei M, Canini A. Chrysin-induced apoptosis is mediated through p38 and Bax activation in B16–F1 and A375 melanoma cells. Int J Oncol. 2011;38(2):473–83. https://doi.org/10.3892/ijo.2010.876.CrossRefPubMed

191.

Pichichero E, Cicconi R, Mattei M, Muzi MG, Canini A. Acacia honey and chrysin reduce proliferation of melanoma cells through alterations in cell cycle progression. Int J Oncol. 2010;37(4):973–81. https://doi.org/10.3892/ijo_00000748.CrossRefPubMed

192.

Tavakoli F, Jahanban-Esfahlan R, Seidi K, Jabbari M, Behzadi R, Pilehvar-Soltanahmadi Y, et al. Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model. Artif Cells Nanomed Biotechnol. 2018;46(sup2):75–86. https://doi.org/10.1080/21691401.2018.1452021.CrossRefPubMed

193.

Xue C, Chen Y, Hu DN, Iacob C, Lu C, Huang Z. Chrysin induces cell apoptosis in human uveal melanoma cells via intrinsic apoptosis. Oncol Lett. 2016;12(6):4813–20. https://doi.org/10.3892/ol.2016.5251.CrossRefPubMedPubMedCentral

194.

Jia WZ, Zhao JC, Sun XL, Yao ZG, Wu HL, Xi ZQ. Additive anticancer effects of chrysin and low dose cisplatin in human malignant glioma cell (U87) proliferation and evaluation of the mechanistic pathway. J BUON. 2015;20(5):1327–36.PubMed

195.

Feng X, Zhou Q, Liu C, Tao ML. Drug screening study using glioma stem-like cells. Mol Med Rep. 2012;6(5):1117–20. https://doi.org/10.3892/mmr.2012.1040.CrossRefPubMed

196.

Wang J, Wang H, Sun K, Wang X, Pan H, Zhu J, et al. Chrysin suppresses proliferation, migration, and invasion in glioblastoma cell lines via mediating the ERK/Nrf2 signaling pathway. Drug Des Devel Ther. 2018;12:721–33. https://doi.org/10.2147/DDDT.S160020.CrossRefPubMedPubMedCentral

197.

Talebi M, Talebi M, Farkhondeh T, Samarghandian S. Biological and therapeutic activities of thymoquinone: focus on the Nrf2 signaling pathway. Phytother Res. 2020. https://doi.org/10.1002/ptr.6905.CrossRefPubMed

198.

Weng MS, Ho YS, Lin JK. Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21Waf1/Cip1 expression: involvement of p38 mitogen-activated protein kinase. Biochem Pharmacol. 2005;69(12):1815–27. https://doi.org/10.1016/j.bcp.2005.03.011.CrossRefPubMed

199.

Somnay YR, Dull BZ, Eide J, Jaskula-Sztul R, Chen H. Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids. Cancer Gene Ther. 2015;22(10):496–505. https://doi.org/10.1038/cgt.2015.49.CrossRefPubMedPubMedCentral

200.

Zaric M, Mitrovic M, Nikolic I, Baskic D, Popovic S, Djurdjevic P, et al. Chrysin induces apoptosis in peripheral blood lymphocytes isolated from human chronic lymphocytic leukemia. Anticancer Agents Med Chem. 2015;15(2):189–95. https://doi.org/10.2174/1871520614666140924123116.CrossRefPubMed

201.

Salimi A, Roudkenar MH, Seydi E, Sadeghi L, Mohseni A, Pirahmadi N, et al. Chrysin as an anti-cancer agent exerts selective toxicity by directly inhibiting mitochondrial complex II and V in CLL B-lymphocytes. Cancer Invest. 2017;35(3):174–86. https://doi.org/10.1080/07357907.2016.1276187.CrossRefPubMed

202.

Lin CC, Yu CS, Yang JS, Lu CC, Chiang JH, Lin JP, et al. Chrysin, a natural and biologically active flavonoid, influences a murine leukemia model in vivo through enhancing populations of T-and B-cells, and promoting macrophage phagocytosis and NK cell cytotoxicity. Vivo. 2012;26(4):665–70.

203.

Pilátová M, Stupáková V, Varinská L, Šarišský M, Mirossay L, Miroššay A, et al. Effect of selected flavones on cancer and endothelial cells. Gen Physiol Biophys. 2010;29(2):134–43. https://doi.org/10.4149/gpb_2010_02_134.CrossRefPubMed

204.

Lee SJ, Yoon JH, Song KS. Chrysin inhibited stem cell factor (SCF)/c-Kit complex-induced cell proliferation in human myeloid leukemia cells. Biochem Pharmacol. 2007;74(2):215–25. https://doi.org/10.1016/j.bcp.2007.04.011.CrossRefPubMed

205.

Woo KJ, Yoo YH, Park JW, Kwon TK. Bcl-2 attenuates anticancer agents-induced apoptosis by sustained activation of Akt/protein kinase B in U937 cells. Apoptosis. 2005;10(6):1333–43. https://doi.org/10.1007/s10495-005-2763-5.CrossRefPubMed

206.

Xiao G, Tang X, Yao C, Wang C. Potentiation of arsenic trioxide-induced apoptosis by 8-bromo-7-methoxychrysin in human leukemia cells involves depletion of intracellular reduced glutathione. Acta Biochim Biophys Sin (Shanghai). 2011;43(9):712–21. https://doi.org/10.1093/abbs/gmr065.CrossRef

207.

Naso L, Ferrer EG, Lezama L, Rojo T, Etcheverry SB, Williams P. Role of oxidative stress in the antitumoral action of a new vanadyl(IV) complex with the flavonoid chrysin in two osteoblast cell lines: relationship with the radical scavenger activity. J Biol Inorg Chem. 2010;15(6):889–902. https://doi.org/10.1007/s00775-010-0652-z.CrossRefPubMed

208.

Berenda J, Smöch C, Stadlbauer C, Mittermair E, Taxauer K, Huttary N, et al. Flavonoids distinctly stabilize lymph endothelial-or blood endothelial disintegration induced by colon cancer spheroids SW620. Molecules. 2020;25(9). https://doi.org/10.3390/molecules25092066.

209.

Prangsaengtong O, Athikomkulchai S, Xu J, Koizumi K, Inujima A, Shibahara N, et al. Chrysin inhibits lymphangiogenesis in vitro. Biol Pharm Bull. 2016;39(4):466–72. https://doi.org/10.1248/bpb.b15-00543.CrossRefPubMed

210.

Lin CM, Shyu KG, Wang BW, Chang H, Chen YH, Chiu JH. Chrysin suppresses IL-6-induced angiogenesis via down-regulation of JAK1/STAT3 and VEGF: an in vitro and in ovo approach. J Agric Food Chem. 2010;58(11):7082–7. https://doi.org/10.1021/jf100421w.CrossRefPubMed

211.

Lin CM, Chang H, Li SY, Wu IH, Chiu JH. Chrysin inhibits lipopolysaccharide-induced angiogenesis via down-regulation of VEGF/VEGFR-2(KDR) and IL-6/IL-6R pathways. Planta Med. 2006;72(8):708–14. https://doi.org/10.1055/s-2006-931602.CrossRefPubMed

212.

Orsolić N, Kosalec I, Basić I. Synergistic antitumor effect of polyphenolic components of water soluble derivative of propolis against Ehrlich ascites tumour. Biol Pharm Bull. 2005;28(4):694–700. https://doi.org/10.1248/bpb.28.694.CrossRefPubMed

213.

Sun LP, Chen AL, Hung HC, Chien YH, Huang JS, Huang CY, et al. Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis. J Agric Food Chem. 2012;60(47):11748–58. https://doi.org/10.1021/jf303261r.CrossRefPubMed

214.

Ramachandran S, Shanmugam M. Chemopreventic potential of chrysin in 7,12-dimethylbenz(a)anthracene induced mammary carcinogenesis in Sprague-Dawley rats. J Cell Tissue Res. 2011;11:2909–18.

215.

Karthikeyan S, Ramachandran S, Wani SA, Shanmugam M. Chemopreventive potential of chrysin in 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis. Int J Nutr Pharmacol Neurol Dis. 2013;3:46–53. https://doi.org/10.4103/2231-0738.106993.CrossRef

216.

Sequetto PL, Oliveira TT, Soares IA, Maldonado IR, Mello VJ, Pizziolo VR, et al. The flavonoid chrysin attenuates colorectal pathological remodeling reducing the number and severity of pre-neoplastic lesions in rats exposed to the carcinogen 1,2-dimethylhydrazine. Cell Tissue Res. 2013;352(2):327–39. https://doi.org/10.1007/s00441-013-1562-5.CrossRefPubMed

217.

Miyamoto S, Kohno H, Suzuki R, Sugie S, Murakami A, Ohigashi H, et al. Preventive effects of chrysin on the development of azoxymethane-induced colonic aberrant crypt foci in rats. Oncol Rep. 2006;15(5):1169–73.PubMed

218.

Quan MF, Xiao LH, Liu ZH, Guo H, Ren KQ, Liu F, et al. 8-Bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin. World J Gastroenterol. 2013;19(43):7680–95. https://doi.org/10.3748/wjg.v19.i43.7680.CrossRefPubMedPubMedCentral

219.

Liu H, Hwang J, Li W, Choi TW, Liu K, Huang Z, et al. A derivative of chrysin suppresses two-stage skin carcinogenesis by inhibiting mitogen- and stress-activated kinase 1. Cancer Prev Res (Phila). 2014;7(1):74–85. https://doi.org/10.1158/1940-6207.CAPR-13-0133.CrossRef

220.

Liu H, Liu K, Huang Z, Park CM, Thimmegowda NR, Jang JH, et al. A chrysin derivative suppresses skin cancer growth by inhibiting cyclin-dependent kinases. J Biol Chem. 2013;288(36):25924–37. https://doi.org/10.1074/jbc.M113.464669.CrossRefPubMedPubMedCentral

221.

Kanwal R, Datt M, Liu X, Gupta S. Dietary flavones as dual inhibitors of DNA methyltransferases and histone methyltransferases. PLoS ONE. 2016;11(9):e0162956. https://doi.org/10.1371/journal.pone.0162956.CrossRefPubMedPubMedCentral

222.

Monasterio A, Urdaci MC, Pinchuk IV, López-Moratalla N, Martínez-Irujo JJ. Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpain-dependent pathways. Nutr Cancer. 2004;50(1):90–100. https://doi.org/10.1207/s15327914nc5001_12.CrossRefPubMed

223.

Woo KJ, Jeong YJ, Park JW, Kwon TK. Chrysin-induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells. Biochem Biophys Res Commun. 2004;325(4):1215–22. https://doi.org/10.1016/j.bbrc.2004.09.225.CrossRefPubMed

224.

von Brandenstein MG, Ngum Abety A, Depping R, Roth T, Koehler M, Dienes HP, et al. A p38–p65 transcription complex induced by endothelin-1 mediates signal transduction in cancer cells. Biochim Biophys Acta. 2008;1783(9):1613–22. https://doi.org/10.1016/j.bbamcr.2008.04.003.CrossRef

225.

Patel RV, Mistry B, Syed R, Rathi AK, Lee YJ, Sung JS, et al. Chrysin-piperazine conjugates as antioxidant and anticancer agents. Eur J Pharm Sci. 2016;88:166–77. https://doi.org/10.1016/j.ejps.2016.02.011.CrossRefPubMed

226.

Gülden M, Appel D, Syska M, Uecker S, Wages F, Seibert H. Chrysin and silibinin sensitize human glioblastoma cells for arsenic trioxide. Food Chem Toxicol. 2017;105:486–97. https://doi.org/10.1016/j.fct.2017.04.035.CrossRefPubMed

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin

Abstract

Graphic abstract

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Graphic abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions

E-cadherin on epithelial–mesenchymal transition in thyroid cancer

TMED3/RPS15A Axis promotes the development and progression of osteosarcoma

The immune landscape of the microenvironment of thyroid cancer is closely related to differentiation status

Downregulation of Tim-1 inhibits the proliferation, migration and invasion of glioblastoma cells via the miR-133a/TGFBR1 axis and the restriction of Wnt/β-catenin pathway

Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics

Keynote webinar | Spotlight on antibody–drug conjugates in cancer